Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.

PURPOSE Recent clinical investigations have shown a strong correlation between pretreatment tumor hypoxia and poor response to radiotherapy. These observations raise questions about standard assumptions of tumor reoxygenation during radiotherapy, which has been poorly studied in human cancers. Positron emission tomography (PET) imaging of [F-18]fluoromisonidazole (FMISO) uptake allows noninvasive assessment of tumor hypoxia, and is amenable for repeated studies during fractionated radiotherapy to systematically evaluate changes in tumor oxygenation. METHODS AND MATERIALS Seven patients with locally advanced nonsmall cell lung cancers underwent sequential [F-18]FMISO PET imaging while receiving primary radiotherapy. Computed tomograms were used to calculate tumor volumes, define tumor extent for PET image analysis, and assist in PET image registration between serial studies. Fractional hypoxic volume (FHV) was calculated for each study as the percentage of pixels within the analyzed imaged tumor volume with a tumor:blood [F-18]FMISO ratio > or = 1.4 by 120 min after injection. Serial FHVs were compared for each patient. RESULTS Pretreatment FHVs ranged from 20-84% (median 58%). Subsequent FHVs varied from 8-79% (median 29%) at midtreatment, and ranged from 3-65% (median 22%) by the end of radiotherapy. One patient had essentially no detectable residual tumor hypoxia by the end of radiation, while two others showed no apparent decrease in serial FHVs. There was no correlation between tumor size and pretreatment FHV. CONCLUSIONS Although there is a general tendency toward improved oxygenation in human tumors during fractionated radiotherapy, these changes are unpredictable and may be insufficient in extent and timing to overcome the negative effects of existing pretreatment hypoxia. Selection of patients for clinical trials addressing radioresistant hypoxic cancers can be appropriately achieved through single pretreatment evaluations of tumor hypoxia.

[1]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  B Palcic,et al.  Reduced oxygen enhancement ratio at low doses of ionizing radiation. , 1984, Radiation research.

[3]  P. Vaupel,et al.  Tumor tissue oxygenation as evaluated by computerized-pO2-histography. , 1990, International journal of radiation oncology, biology, physics.

[4]  T W Griffin,et al.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.

[5]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.

[6]  C. Mathis,et al.  A radiosynthesis of fluorine-18 fluoromisonidazole. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Hanley,et al.  Hyperbaric oxygen therapy for carcinoma of the cervix--stages IIB, IIIA, IIIB and IVA: results of a randomized study by the Radiation Therapy Oncology Group. , 1981, International journal of radiation oncology, biology, physics.

[8]  M. Parliament,et al.  Imaging tumor hypoxia and tumor perfusion. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  P Kolstad,et al.  Intercapillary distance, oxygen tension and local recurrence in cervix cancer. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[10]  S. Dische.  Hyperbaric oxygen: the Medical Research Council trials and their clinical significance. , 1978, The British journal of radiology.

[11]  I. Silver,et al.  Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapy. , 1960, Acta radiologica.

[12]  J. Rasey,et al.  Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. , 1990, Radiation research.

[13]  L. Prosnitz,et al.  Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck. , 1989, International journal of radiation oncology, biology, physics.

[14]  D. Hirst.  Anemia: a problem or an opportunity in radiotherapy? , 1986, International Journal of Radiation Oncology, Biology, Physics.

[15]  G. Fletcher,et al.  Keynote address—the problem: Tumor radioresistance in clinical radiotherapy , 1982 .

[16]  N. D. Harvey,et al.  Radiation therapy in hyperbaric oxygen for head and neck cancer at Royal Adelaide Hospital--1964 to 1980. , 1987, International journal of radiation oncology, biology, physics.

[17]  S. Rockwell,et al.  Hypoxic fractions of human tumors xenografted into mice: a review. , 1990, International journal of radiation oncology, biology, physics.

[18]  R. Gatenby,et al.  Oxygen tension in human tumors: in vivo mapping using CT-guided probes. , 1985, Radiology.

[19]  S. Dische.  Keynote address: hypoxic cell sensitizers: clinical developments. , 1989, International Journal of Radiation Oncology, Biology, Physics.

[20]  T. Griffin.  Fast neutron radiation therapy. , 1992, Critical reviews in oncology/hematology.

[21]  R. Gatenby,et al.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. , 1988, International journal of radiation oncology, biology, physics.

[22]  A. Vacek,et al.  Oxygen tension and prediction of the radiation response. Polarographic study in human breast cancer. , 1982, Neoplasma.

[23]  R. Bush.  The significance of anemia in clinical radiation therapy. , 1986, International journal of radiation oncology, biology, physics.

[24]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .

[25]  S. Dische,et al.  Hemoglobin, radiation, morbidity and survival. , 1986, International journal of radiation oncology, biology, physics.

[26]  P Okunieff,et al.  Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. , 1993, International journal of radiation oncology, biology, physics.

[27]  L. V. van Putten,et al.  Oxygenation status of a transplantable tumor during fractionated radiation therapy. , 1968, Journal of the National Cancer Institute.

[28]  J. Fowler,et al.  Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. I. The biological and physical advantages and problems of neutron therapy. , 1963, The British journal of radiology.

[29]  S. Rockwell,et al.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.